Sculptor Capital’s Amgen AMGN Stock Holding History

Sculptor Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-353,700	Closed	-$57.4M	–	350
2015 Q4	$57.4M	Sell	353,700 -154,300	-30%	-$24.3M	0.31%	78
2015 Q3	$70.3M	Buy	+508,000	New	+$80.1M	0.24%	83
2015 Q1	–	Sell	-28,400	Closed	-$4.52M	–	417
2014 Q4	$4.52M	Sell	28,400 -723,800	-96%	-$113M	0.01%	478
2014 Q3	$106M	Buy	752,200 +345,900	+85%	+$45.2M	0.31%	76
2014 Q2	$48.1M	Buy	406,300 +204,300	+101%	+$23.6M	0.14%	155
2014 Q1	$24.9M	Sell	202,000 -95,700	-32%	-$11.6M	0.08%	228
2013 Q4	$34M	Sell	297,700 -175,200	-37%	-$19.9M	0.09%	268
2013 Q3	$52.9M	Sell	472,900 -14,600	-3%	-$1.58M	0.15%	191
2013 Q2	$48.1M	Buy	+487,500	New	+$50.6M	0.15%	186

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Sculptor Capital's AMGN Position: Q1 2016 in Review

Sculptor Capital sold out of Amgen (AMGN) in Q1 2016, closing a stake of 6,792 shares — an estimated $1.1M sold.

Sculptor Capital first reported a position in AMGN in Q2 2014 and held it in 4 quarters. The position peaked at $24.1M in Q3 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

Sculptor Capital reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
Sculptor Capital sold 6,792 Amgen shares in Q1 2016, an estimated $1.1M.
Sculptor Capital first reported a position in Amgen in Q2 2014 and held it in 4 quarters.
Sculptor Capital's Amgen position peaked at $24.1M in Q3 2015.
1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Sculptor Capital's 13F filing for Q1 2016, filed 16 May 2016.